Martens P - Search Results

1

Renal function and decongestion with acetazolamide in acute decompensated heart failure: the ADVOR trial.

Meekers E, Dauw J, Martens P, Dhont S, Verbrugge FH, Nijst P, Ter Maaten JM, Damman K, Mebazaa A, Filippatos G, Ruschitzka F, Tang WHW, Dupont M, Mullens W. Meekers E, et al. Among authors: martens p. Eur Heart J. 2023 Oct 1;44(37):3672-3682. doi: 10.1093/eurheartj/ehad557. Eur Heart J. 2023. PMID: 37623428 Clinical Trial.

2

Current Approach to Decongestive Therapy in Acute Heart Failure.

Martens P, Nijst P, Mullens W. Martens P, et al. Curr Heart Fail Rep. 2015 Dec;12(6):367-78. doi: 10.1007/s11897-015-0273-5. Curr Heart Fail Rep. 2015. PMID: 26486631 Review.

3

Plasma Volume Is Normal but Heterogeneously Distributed, and True Anemia Is Highly Prevalent in Patients With Stable Heart Failure.

Nijst P, Verbrugge FH, Bertrand PB, Martens P, Dupont M, Drieskens O, Penders J, Tang WH, Mullens W. Nijst P, et al. Among authors: martens p. J Card Fail. 2017 Feb;23(2):138-144. doi: 10.1016/j.cardfail.2016.08.008. Epub 2016 Aug 22. J Card Fail. 2017. PMID: 27561853

4

Mode of Death in Octogenarians Treated With Cardiac Resynchronization Therapy.

Martens P, Verbrugge FH, Nijst P, Dupont M, Mullens W. Martens P, et al. J Card Fail. 2016 Dec;22(12):970-977. doi: 10.1016/j.cardfail.2016.09.023. Epub 2016 Oct 4. J Card Fail. 2016. PMID: 27717763

5

Impact of Iron Deficiency on Response to and Remodeling After Cardiac Resynchronization Therapy.

Martens P, Verbrugge F, Nijst P, Dupont M, Tang WH, Mullens W. Martens P, et al. Am J Cardiol. 2017 Jan 1;119(1):65-70. doi: 10.1016/j.amjcard.2016.09.017. Epub 2016 Sep 29. Am J Cardiol. 2017. PMID: 27780556

6

Optimizing CRT - Do We Need More Leads and Delivery Methods.

Martens P, Verbrugge FH, Mullens W. Martens P, et al. J Atr Fibrillation. 2015 Apr 30;7(6):1202. doi: 10.4022/jafib.1202. eCollection 2015 Apr-May. J Atr Fibrillation. 2015. PMID: 27957161 Free PMC article. Review.

7

Feasibility and Association of Neurohumoral Blocker Up-titration After Cardiac Resynchronization Therapy.

Martens P, Verbrugge FH, Nijst P, Bertrand PB, Dupont M, Tang WH, Mullens W. Martens P, et al. J Card Fail. 2017 Aug;23(8):597-605. doi: 10.1016/j.cardfail.2017.03.001. Epub 2017 Mar 8. J Card Fail. 2017. PMID: 28284756

8

Promise of SGLT2 Inhibitors in Heart Failure: Diabetes and Beyond.

Martens P, Mathieu C, Verbrugge FH. Martens P, et al. Curr Treat Options Cardiovasc Med. 2017 Mar;19(3):23. doi: 10.1007/s11936-017-0522-x. Curr Treat Options Cardiovasc Med. 2017. PMID: 28299616 Review.

9

Changes in Loop Diuretic Dose and Outcome After Cardiac Resynchronization Therapy in Patients With Heart Failure and Reduced Left Ventricular Ejection Fractions.

Martens P, Verbrugge FH, Nijst P, Dupont M, Mullens W. Martens P, et al. Am J Cardiol. 2017 Jul 15;120(2):267-273. doi: 10.1016/j.amjcard.2017.04.021. Epub 2017 Apr 27. Am J Cardiol. 2017. PMID: 28532770

10

Renal response to intravascular volume expansion in euvolemic heart failure patients with reduced ejection fraction: Mechanistic insights and clinical implications.

Nijst P, Verbrugge FH, Martens P, Dupont M, Tang WHW, Mullens W. Nijst P, et al. Among authors: martens p. Int J Cardiol. 2017 Sep 15;243:318-325. doi: 10.1016/j.ijcard.2017.05.041. Epub 2017 May 14. Int J Cardiol. 2017. PMID: 28545850

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

559 results

Search Page

Filters